RecruitingNCT06661174

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy


Sponsor

China-Japan Friendship Hospital

Enrollment

100 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a prediction model for the improvement of renal outcomes after weight loss.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Age 18 to 65 years old;
  • BMI>25Kg/m2 or abdominal obesity (i.e. waist circumference>90cm for men and>85cm for women);
  • eGFR<30ml/min/1.73m2 or urinary microalbumin≥300mg/g, eGFR<60ml/min/1.73m2.

Exclusion Criteria2

  • Patients who are taking glucocorticoids;
  • Combined with tumors; ③Combined with autoimmune diseases; ④Serum albumin<25g/L.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBariatric surgery

Laparoscopic sleeve gastrectomy or laparoscopic gastric bypass based on β-cell function

OTHERNon-surgical therapy

Diet management,exercise,metformin,GLP-1 receptor agonists and other drugs which can lose weight.


Locations(1)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06661174


Related Trials